Center of Expertise in Palliative Care, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, The Netherlands.
Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, University Utrecht, The Netherlands.
Cancer Med. 2020 Sep;9(17):6111-6121. doi: 10.1002/cam4.3253. Epub 2020 Jul 9.
The Utrecht Symptom Diary (USD) is a Dutch and adapted version of the Edmonton Symptom Assessment System, a patient-reported outcome measurement (PROM) tool to asses and monitor symptoms in cancer patients. This study analyses the validity and responsiveness of the USD and the cutoff points to determine the clinical significance of a symptom score.
Observational longitudinal cohort study including adult in- and outpatients treated in an academic hospital in the Netherlands who completed at least one USD as part of routine care (2012-2019). The distress thermometer and problem checklist (DT&PC) was used as a reference PROM. Content, construct and criterion validity, responsiveness, and cutoff points are shown with prevalences, area under receiver operating characteristic (ROC) curve, Chi-squared test, Wilcoxon signed-rank test, and positive and negative predictive values, respectively.
A total of 3913 patients completed 22 400 USDs. Content validity was confirmed for all added USD items with prevalences of ≥22%. All USD items also present on the DT&PC demonstrated a good criterion validity (ROC >0.8). Construct validity was confirmed for the USD as a whole and for the items dry mouth, dysphagia and well-being (P < .0001). USD scores differed significantly for patients when improving or deteriorating on the DT&PC which confirmed responsiveness. Optimal cutoff points (3 or 4) differed per symptom.
The USD is a valid 12-item PROM for the most prevalent symptoms in cancer patients, which has content, criterion, and construct validity, and detects clinically important changes over time, in both curative and palliative phase.
乌得勒支症状日记(USD)是埃德蒙顿症状评估系统的荷兰语和改编版本,是一种患者报告的结局测量(PROM)工具,用于评估和监测癌症患者的症状。本研究分析了 USD 的有效性和反应性以及截断值,以确定症状评分的临床意义。
这是一项观察性纵向队列研究,纳入了在荷兰一家学术医院接受治疗的成年住院和门诊患者,他们在常规护理中至少完成了一次 USD(2012-2019 年)。使用痛苦温度计和问题清单(DT&PC)作为参考 PROM。显示内容、结构和标准有效性、反应性和截断值的方法分别为流行率、接收器操作特征(ROC)曲线下面积、卡方检验、Wilcoxon 符号秩检验以及阳性和阴性预测值。
共有 3913 名患者完成了 22400 次 USD。所有新增 USD 项目的内容有效性均得到确认,其流行率均≥22%。所有在 DT&PC 上出现的 USD 项目也具有良好的标准有效性(ROC >0.8)。USD 作为一个整体以及口干、吞咽困难和幸福感等项目的结构有效性得到了确认(P<.0001)。当 DT&PC 上的患者病情改善或恶化时,USD 评分存在显著差异,这证实了其反应性。每个症状的最佳截断值(3 或 4)不同。
USD 是一种针对癌症患者最常见症状的有效 12 项 PROM,具有内容、标准和结构有效性,并且可以检测到随着时间推移的临床重要变化,无论是在治疗期还是姑息期。